Liver International

2018

DOI: 10.1111/liv.13703

|View full text |Cite

|

Sign up to set email alerts

|

Aetiology of hepatocellular carcinoma in South America

Antonio Ponzetto

¹

,

Francesco Arcangelo Diella

²

,

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Olgu Sunumu1

Citation Types

Supporting

0

Mentioning

0

Contrasting

0

Unclassified

1

Year Published

2018

2018

2019

2019

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(1 citation statement)

References 4 publications

Supporting

0

Mentioning

0

Contrasting

0

Unclassified

1

Order By: Relevance

“…Ancak AFP > 50 olması, tümörün damar invazyonu veya uzak organ metastazı varlığında yapılacak transplantasyonda bir yıllık yaşam şansı %90'ın altındadır. Bu nedenle erken evrede yakalanan HSK olgularının tedavi şansı yüksektir [5][6][7][8] . Bizim olgumuzda AFP sınırda yüksek olmasına karşın, büyük tümör ve damar invazyonu nedeniyle hasta karaciğer transplantasyon şansını yitirmiştir.…”

Section: Olgu Sunumuunclassified

Cure in Chronic Hepatitis C! Does it Prevent the Risk of Hepatocellular Carcinoma?

2018

View full text Add to dashboard Cite

In 5%-20% of chronic HCV patients, cirrhosis or other complications like liver cancer may be seen and these may be directly or undirectly related. The development of a sustained viral response (SVR) does not change this fact. In the case of a 52-year-old female diabetic Çelen MK, Akdemir İ, Bayan K.

“…Ancak AFP > 50 olması, tümörün damar invazyonu veya uzak organ metastazı varlığında yapılacak transplantasyonda bir yıllık yaşam şansı %90'ın altındadır. Bu nedenle erken evrede yakalanan HSK olgularının tedavi şansı yüksektir [5][6][7][8] . Bizim olgumuzda AFP sınırda yüksek olmasına karşın, büyük tümör ve damar invazyonu nedeniyle hasta karaciğer transplantasyon şansını yitirmiştir.…”

Section: Olgu Sunumuunclassified

Cure in Chronic Hepatitis C! Does it Prevent the Risk of Hepatocellular Carcinoma?

2018

View full text Add to dashboard Cite

In 5%-20% of chronic HCV patients, cirrhosis or other complications like liver cancer may be seen and these may be directly or undirectly related. The development of a sustained viral response (SVR) does not change this fact. In the case of a 52-year-old female diabetic Çelen MK, Akdemir İ, Bayan K.

On hepatocellular carcinoma in South America and early-age onset of the disease

¹

,

²

,

³

et al. 2019

Clinics and Research in Hepatology and Gastroenterology

View full text Add to dashboard Cite

No abstract

Early hepatocellular carcinoma in South America: What is to blame?

¹

2018

Liver International

View full text Add to dashboard Cite

No abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Product

Browser Extension Assistant by scite Citation Statement Search Reference Check Visualizations Dashboards Explore Journals Explore Organizations Explore Funders Embedding Badge Embedding Citation Search Pricing

Resources

Blog Help & FAQ Accessibility Statement API Terms For Universities & Governments For Researchers For Publishers For Corporate, Pharma & Enterprise Author Marketing Become an Affiliate Get an organization trial or quote scite Data & Services

About

News & Press Careers Read our Paper Coverage

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.